Loading…
Loading…
LSB (LakeShore Biopharma Co., Ltd) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
LSB Industries is rated Buy with a $13.50 target, leveraging a structural U.S. natural gas cost advantage over European peers. Operational efficiency gains, particularly at the El Dorado plant, and a flexible product mix support margin expansion and resilience against agricultural price swings. The carbon capture project is expected to generate $25–30 million in annual cash flow by 2027, with regulatory and execution risks to monitor.
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the second quarter ended June 30, 2026. Second Quarter 2026 Results and Recent Highlights Net sales of $168.1 million compared to $151.3 million in the second quarter of 2025 Net loss of $6.2 million, inclusive of approximately $28.8 million of turnaround expenses, compared to net income of $3.0 million in the second quarter of 2025, inclusive of approximatel.
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the second quarter ended June 30, 2026 on July 29, 2026 after the close of the stock market.LSB's management will host a conference call on Thursday, July 30, 2026 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Officer, C.
LSB Industries, a top-5 U.S. ammonia producer, and a nitrogen-oriented chemical specialist has outperforming other material peers and the Russell 2000 meaningfully this year. Despite facing 900bps of potential margin expansion this year, LXU trades at a forward EV/EBITDA of 5.15x–5.25x, over 20% below its 5-year average, and a 60% discount to the sector. Margin growth is driven by strong pricing growth, higher-value downstream products, a greater share of cost-plus contracts, and ongoing process improvements.
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB” or “the Company”), today announced that it has reached an agreement with Lapis Carbon Solutions (“Lapis”) that establishes a strategic pathway for LSB to take full ownership of Project Blue, the carbon capture and sequestration (“CCS”) project currently underway at its El Dorado, Arkansas facility (“the Project”). “The opportunity to achieve full ownership of this project is an important strategic step for the Company,” sai.
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or “the Company”) (OTC: LSBCF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the first quarter ended March 31, 2026. First Quarter 2026 Results and Recent Highlights Net sales of $169.5 million compared to $143.4 million in the first quarter of 2025 Net income of $19.7 million compared to a net loss of $1.6 million in the first quarter of 2025 Diluted EPS of $0.27 compared to $(0.02) for the first quarter of 2025 Adjusted EBITDA(1) of.
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the first quarter ended March 31, 2026 on April 29, 2026 after the close of the stock market. LSB's management will host a conference call on Thursday, April 30, 2026 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Office.